✦ LIBER ✦

P2.095 Risperidone in children with disruptive behavior disorders: A 2-year open-label trial

✍ Scribed by M. Reyes-Harde; J. Croonenberghs; M. Eerdekens

Book ID: 118590677
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 114 KB
Volume: 14
Category: Article
ISSN: 0924-977X
DOI: 10.1016/s0924-977x(04)80315-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P2.101 Risperidone prevents relapses of

P2.101 Risperidone prevents relapses of disruptive behavioral disorders in children and adolescents of average intelligence: A 6-month trial of risperidone versus placebo

✍ M. Reyes-Harde; J.K. Buitelaar; I. Augustyns; M. Eerdekens 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 230 KB

P.7.024 A prospective open-label long-te

P.7.024 A prospective open-label long-term treatment trial of risperidone monotherapy in children and adolescents with bipolar disorder

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 243 KB

Improvement in social functioning in out

Improvement in social functioning in outpatients with schizophrenia with prominent negative symptoms treated with olanzapine or risperidone in a 1 year randomized, open-label trial

✍ Antonio Ciudad; José M. Olivares; Manuel Bousoño; Juan C. Gómez; Enrique Álvarez 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 291 KB

Safety and efficacy of long-acting injec

Safety and efficacy of long-acting injectable risperidone in patients with schizophrenia spectrum disorders: A 6-month open-label trial in Asian patients

✍ Swapna Verma; Mythily Subramaniam; Edimansyah Abdin; Kang Sim; Alex Su; Nelson L 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB 👁 2 views

## Abstract The study aimed to evaluate the efficacy of long‐acting injectable risperidone (LAR) in Asian patients with schizophrenia spectrum disorders. Twenty‐five patients enrolled in this 6‐month open labelled study. They were switched from their current antipsychotic to LAR without a prior or

Association of dopamine transporter geno

Association of dopamine transporter genotype with disruptive behavior disorders in an eight-year longitudinal study of children and adolescents

✍ Steve S. Lee; Benjamin B. Lahey; Irwin Waldman; Carol A. Van Hulle; Paul Rathouz 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB 👁 3 views

P.2.e.018 Switching from olanzapine to z

P.2.e.018 Switching from olanzapine to ziprasidone in patients with bipolar disorder: a 24-weeks, multi-center open-label trial

✍ B. Yoon; W. Bahk; K. Min; D. Jon; Y. Shin; S. Lee 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 59 KB